[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Next Article in Journal
Forthcoming Challenges in Mycotoxins Toxicology Research for Safer Food—A Need for Multi-Omics Approach
Next Article in Special Issue
Novel Aflatoxin-Degrading Enzyme from Bacillus shackletonii L7
Previous Article in Journal
Deoxynivalenol (DON) Contamination of Feed and Grinding Fineness: Are There Interactive Implications on Stomach Integrity and Health of Piglets?
Previous Article in Special Issue
Ameliorating Effects of Bacillus subtilis ANSB060 on Growth Performance, Antioxidant Functions, and Aflatoxin Residues in Ducks Fed Diets Contaminated with Aflatoxins
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Degradation of Aflatoxins by Means of Laccases from Trametes versicolor: An In Silico Insight

by
Luca Dellafiora
1,
Gianni Galaverna
1,*,
Massimo Reverberi
2 and
Chiara Dall’Asta
1
1
Department of Food Science, University of Parma, 43124 Parma, Italy
2
Department of Environmental Biology, Sapienza University, 00185 Rome, Italy
*
Author to whom correspondence should be addressed.
Toxins 2017, 9(1), 17; https://doi.org/10.3390/toxins9010017
Submission received: 16 November 2016 / Revised: 16 December 2016 / Accepted: 26 December 2016 / Published: 1 January 2017
Graphical abstract
">
Figure 1
<p>Chemical structure of aflatoxin B<sub>1</sub> (<b>A</b>) and aflatoxin M<sub>1</sub> (<b>B</b>).</p> ">
Figure 2
<p>The sequence alignment (<b>A</b>) and pharmacophoric analysis of beta (<b>B</b>), gamma (<b>C</b>) and delta (<b>D</b>) laccase isoforms from <span class="html-italic">T. versicolor</span>. In the sequence alignment (box <b>A</b>), dots represent matching residues while dashes indicate gaps (<b>red</b> spots in the gap fraction <b>blue</b> bar). Residues of the binding site are highlighted in <b>yellow</b> while the <b>green</b> box indicates an extended region of the gamma isoform lining the catalytic site. The overall 3D structure of the beta isoform is also reported to provide localization of the binding site (colored in <b>yellow</b>). In the pharmacophoric analysis (boxes <b>B</b>, <b>C</b> and <b>D</b>), <b>white</b>, <b>red</b>, and <b>blue</b> contours identify regions sterically and energetically favorable for hydrophobic, H-bond acceptor, and H-bond donor groups, respectively. Spheres indicate Cu ions. The <b>green</b> box indicates the extended region of the gamma isoform.</p> ">
Figure 3
<p>Binding architecture of ABTS. Proteins are represented in cartoon and surface, ABTS and residues of binding sites are represented in sticks. Cu at the T1 site is represented by the <b>red</b> sphere and the catalytic histidine is colored in <b>red</b>. ABTS electron donor region is highlighted with the <b>yellow</b> box, while interatomic distances are indicated by <b>yellow</b> dashed lines. (<b>A</b>) calculated surface interaction with beta laccase from <span class="html-italic">T. versicolor</span>; (<b>B</b>) crystallographic surface interaction with CotA laccase from <span class="html-italic">Bacillus subtilis</span> [<a href="#B29-toxins-09-00017" class="html-bibr">29</a>]; (<b>C</b>) detail of binding architecture with beta laccase from <span class="html-italic">T. versicolor</span>; and (<b>D</b>) detail of binding architecture with CotA laccase from <span class="html-italic">B. subtilis</span> [<a href="#B29-toxins-09-00017" class="html-bibr">29</a>].</p> ">
Figure 4
<p>Binding architecture of AFB<sub>1</sub> (<b>A</b>) and AFM<sub>1</sub> (<b>B</b>) within the beta isoform. Proteins are represented in with cartoons and cut surfaces, and ligands and amino acids side-chains are represented with sticks. The Cu ions are represented with spheres. <b>Yellow</b> dotted lines indicate H-bonds.</p> ">
Figure 5
<p>Details of ligand binding site of laccase isoforms. Proteins are represented with cut surfaces and ligands with sticks. The <b>yellow</b> box indicates the additional volume in the gamma isoform binding site due to the presence of the extended loop. (<b>A</b>) AFB<sub>1</sub> within the beta isoform pocket; (<b>B</b>) AFB<sub>1</sub> within the delta isoform pocket; and (<b>C</b>) gamma isoform pocket.</p> ">
Versions Notes

Abstract

:
Mycotoxins are secondary metabolites of fungi that contaminate food and feed, and are involved in a series of foodborne illnesses and disorders in humans and animals. The mitigation of mycotoxin content via enzymatic degradation is a strategy to ensure safer food and feed, and to address the forthcoming issues in view of the global trade and sustainability. Nevertheless, the search for active enzymes is still challenging and time-consuming. The in silico analysis may strongly support the research by providing the evidence-based hierarchization of enzymes for a rational design of more effective experimental trials. The present work dealt with the degradation of aflatoxin B1 and M1 by laccase enzymes from Trametes versicolor. The enzymes–substrate interaction for various enzyme isoforms was investigated through 3D molecular modeling techniques. Structural differences among the isoforms have been pinpointed, which may cause different patterns of interaction between aflatoxin B1 and M1. The possible formation of different products of degradation can be argued accordingly. Moreover, the laccase gamma isoform was identified as the most suitable for protein engineering aimed at ameliorating the substrate specificity. Overall, 3D modeling proved to be an effective analytical tool to assess the enzyme–substrate interaction and provided a solid foothold for supporting the search of degrading enzyme at the early stage.

Graphical Abstract">

Graphical Abstract

1. Introduction

Mycotoxins are low-molecular weight molecules produced as secondary metabolites by several species of fungi. They may enter the feed and food production chains worldwide upon the infection of crops and commodities intended for animal and human consumption. The contamination of food and feed by mycotoxins poses major concerns for the public health and welfare as the dietary exposure may cause disorders, dysfunctions and alterations of physiological states in both humans and animals [1,2].
Many countries have adopted regulations to reduce the possible dietary intake, thereby preserving the health of animals and consumers (for Europe: EC No 1881/2006, EU No 165/2010, EU No 105/2010). However, the allowed levels of contamination are not harmonized among countries, and this may cause trade frictions at the global level. De facto, the management of risks related to foodborne mycotoxins must consider several factors and have to reach controversial socio-economical tradeoffs, being primarily influenced by the availability of a secure food supply. The developing areas are the most damaged in terms of health and international exchanges as the contamination levels commonly found in traded commodities do not often comply with those enforced by industrialized countries, also considering that low-income countries lack regulatory actions and monitoring plans. As an example, the restrictions of the European Regulation cause huge economic losses to Africa, unreasonably exceeding the limits to effectively safeguard the public health in the European countries, as commented by the past Secretary-General of the United Nations, Kofi Annan [3].
On this basis, the mitigation of mycotoxin content in food and feed is a critical foothold to address the forthcoming challenges in view of the sustainability and global trade. On the one side, the reduction of contamination levels in food and feed can effectively ameliorate the health and welfare of both humans and animals. On the other side, the implementation of cost-effective strategies for recovering contaminated food and raw materials after spoilage may concretely allow the weaker markets to reenter the global trade. In this scenario, the development of affordable and straightforward strategies for mitigating mycotoxin content is definitely a major task for the scientific research.
A wide number of strategies for the control and mitigation of mycotoxins content in food and feed are currently under consideration. For instance, the strategies of biocontrol with non-toxigenic fungi, conventional breeding and genetic engineering are promising methodologies aimed at preventing the accumulation of mycotoxins on the field at the pre-harvest level [4]. Instead, food processing, physical methods (e.g., irradiation and adsorption) and microbial/biochemical transformation of mycotoxins to non- or less toxic compounds may act post-harvest on raw material or intermediate products [4]. The main advantage of the latter approach on the former is the possible application to low- or non-compliant food batches to reduce and/or reuse wastes. Among these, the enzymatic transformation seems to be the most promising tool for the mitigation in situ [5].
The high-throughput search and optimization of effective enzymes to be used for mitigation is thus of primary interest, even though highly challenging and time-consuming. Typically, the first steps in the conventional large-scale research process of active enzymes inevitably include the coarse-grained selection of candidate enzymes, which drastically depends on the realistic affordability of proteins in sufficient amounts and/or in the active forms. Commonly, this hardly complies with the rational criteria of exclusion in terms of possible effectiveness. However, the search of putative active enzymes in the early steps can be effectively boosted in a straightforward and cost-effective manner by using screening procedures in silico. Indeed, the upstream use of computational approaches to screen the libraries of candidate enzymes may support a wide-ranging and evidence-based selection of those enzymes to be investigated experimentally. In particular, the use of the 3D modeling by means of the computational estimate of the interaction at the enzymes binding site deepens the structural aspects underlying the enzyme–substrate interaction and succeeds in identifying substrates (e.g., ref. [6,7]). Hence, it can be a reliable tool for providing the rational and evidence-based hierarchization of enzymes on the basis of the computed capability to allow a favorable arrangement of substrates.
In this framework, the present study addressed the enzymatic degradation of aflatoxins (AFs) by laccase enzymes from Trametes versicolor. AFs are difuranocoumarin derivatives produced by Asperigillus sect. Flavi that can be found as contaminants primarily in cereals, maize, oilseeds and nuts [8]. AFs are mutagenic, genotoxic and carcinogenic compounds that cause both acute and chronic health effects [9]. Among the 20 AFs identified so far, aflatoxin B1 (AFB1) is the most widespread and harmful in terms of both acute and chronic toxicity [10], while aflatoxin M1 (AFM1)—its major hepatic metabolite in mammals—raises concern as it can be found in milk and dairy products [11]. In recent years, severe outbreaks related to aflatoxin contamination in feed have been reported in Europe, mainly in the Mediterranean and Balkan areas [12]. Besides health concerns, these events caused significant losses in terms of veterinary costs and managing of incompliant feed and milk batches.
Laccases are multi-copper containing enzymes capable of performing one electron oxidation of a broad range of substrates [13]. The laccase enzymes from T. versicolor have been identified as a promising route for the low-cost and effective reduction of AFB1 content [14,15], while the use of these enzymes has been never considered before to degrade AFM1. Moreover, the strategies commonly rely on the use of mixtures of the various laccase isoforms. The relative activity of the various isoforms and the structural aspects of aflatoxin interaction have not been elucidated yet, making the design of rational strategies based on selected isoforms difficult.
As a proof of concept, the present work aimed at modeling the interaction of AFB1 and AFM1 (Figure 1) with three out four laccase isoforms from T. versicolor (namely, the beta, delta and gamma isoforms) in order to find out possible differences among the enzymes in terms of pocket–ligand recognition. The complementarity of both AFB1 and AFM1 towards the various catalytic sites has been assessed using a previously validated structure-based molecular modeling workflow based on docking simulation and rescoring procedures. The pharmacophoric analysis of catalytic sites and the comparison of structures and sequences of the various isoforms have been done to better understand the basis of the enzymes–substrates interaction at a molecular level.

2. Results

2.1. Sequence Analysis and Pocket Anatomy

Laccases from T. versicolor show a globular structure with approximate dimensions of 70 × 50 × 50 Å with a topology consisting mainly of antiparallel β-barrels [16]. The overall amino acids sequence alignment of the laccase enzymes (from here on referred to as models) revealed that the delta and gamma isoforms showed, respectively, 71.6% and 71.8% of the identity with the beta isoform, and 77% between themselves (Figure 2A).
Concerning the primary structure, the sequence alignment revealed that the binding site of the beta and delta isoforms appeared fairly comparable to each other (12 residues out of 16 are conserved). Instead, the gamma model showed a higher divergence mainly due to the presence of an extend loop with five and four additional residues in respect to the beta and delta isoforms, respectively (Figure 2A,D).
The pharmacophoric analysis of the various binding site environments revealed that all the pockets appeared prevalently hydrophobic, as the hydrophobic environment turned out to exceed in extension the hydrophilic one, with a limited capability to receive polar groups, wherein H-bond donors groups were found to be more energetically favored than the H-bond acceptor ones (Figure 2B–D). In addition, concerning the distribution of the polarity of the space available for ligands, the binding sites of beta and delta isoforms were found to be more similar to each other, while the site of the gamma isoform was found to be less hydrophobic with a more extended volume energetically able to receive H-bond donor groups.

2.2. Assessment of Procedure Reliability

The in silico investigation of AF-laccase interactions relied on the assessment of pocket–substrate complementarity through the coupling of docking simulation to calculate the binding architecture with re-scoring procedures using the HINT (Hydropathic INTeractions) scoring function for the careful estimation of the energetic contributions of the binding event (see Section 5 for further details). Such a procedure already proved to be an effective strategy for investigating the protein–ligand complex formation and the biological activity of chemicals, [17,18], and succeeded in identifying enzymes substrates as well [6]. However, the case-by-case assessment of procedural performances is required to prove the fit-for-purpose reliability among the diverse case studies [19].
Therefore, in the present work, the two benchmark laccase substrates ABTS (2,2′-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid) and 2,6-dimethoxyphenol [20] have been chosen to assess the case-specific reliability of the computational procedure. Specifically, the procedure has been validated assessing the capability to properly rank the reference compounds in accordance with the experimental data from the literature, and for the capability to reproduce the 3D binding architecture observed in the crystallographic structures available so far. The Km values indicate the enzymes affinity for substrates. Thus, the Kms have been chosen among the various biochemical parameters for the comparison with the computed scores since the HINT scoring may correlate the pocket–ligand affinity proportionally [6,21,22,23,24,25].
ABTS showed a clearly defined rank of Kms among the various isoforms, with the following order: 88 μM in beta < 359 μM in gamma < 2262 μM in delta [26]. As shown in Table 1, the computational ranking of ABTS among the various laccase isoforms was consistent with that observed experimentally.
Moreover, while the beta isoform wild type shows a higher affinity for ABTS than for 2,6-dimethoxyphenol, previous studies demonstrated that the D206A mutation at the level of binding site causes the inversion of ranking [20,27]. As reported in Table 2, the computational ranking of ABTS and 2,6-dimethoxyphenol within both the mutated and wild type enzyme was consistent with that observed experimentally.
In order to assess the reliability of the procedure in predicting the binding architectures, the computed pose of ABTS within the beta isoform was compared with the crystallographic one within the orthologous laccase enzyme from Bacillus subtilis, as no structures of laccases from T. versicolor are available so far. They can be consistently compared as orthology allows taking the functional conservation in different species for granted (i.e., the catalytic reaction and the overall organization of substrates in this case) [28]. It should be kept in mind that laccase enzymes catalyze the one-electron oxidation of substrates involving a Cu ion (at the so-called Cu T1 site), coupled to the four-electron reduction of molecular oxygen to water at the tri-nuclear Cu cluster [27]. The catalytic histidine lining the binding site, which may interact with substrates, mediates the electron transfer. For a proper transfer, the distance of the electron–donor regions of substrates from the receiving histidine cannot exceed the 5 Å [26]. The inspection of the crystallographic pose of ABTS revealed that the electron–donor region occupies the deepest region of the binding site, closely arranged to the catalytic histidine, while sulfonic acid groups protrude outside. Therefore, the geometric reliability of the in silico procedure was established by assessing the capability to properly reproduce such binding architecture. As showed in Figure 3, the overall computed organization of ABTS turned out to be consistent with the crystallographic pose and the arrangement of the electron–donor region has been correctly predicted as well, being posed within the 5 Å needed for undergoing the reaction [27].

2.3. Interaction of Aflatoxin B1 and M1 within Beta, Delta and Gamma Laccase Isoforms

The scores of interactions between AFs and laccase isoforms are reported in Table 3. AFM1 was found able to interact favorably with all the laccase isoforms herein considered. AFB1 favorably interacted instead with beta and delta, but not with gamma, as the pharmacophoric requirements were not satisfied (see below).
The close inspection of the computed poses revealed that AFB1 adopted comparable binding architectures within both the beta and delta laccase isoforms, wherein the methoxy moiety was oriented toward the bottom of the binding sites. Both the interactions were mainly driven by hydrophobic/hydrophobic interaction, in accordance with the marked hydrophobic environment of the pockets. Indeed, a unique polar contact was found, wherein the oxygen of the methoxy group engaged the His458 (according to the amino acids’ numeration of the beta isoform) with a hydrogen bond (Figure 4A). AFM1 engaged the His458 with the oxygen on the difuran ring and used the additional hydroxyl group for engaging Asp206 (according to the amino acids’ numeration of the beta isoform), thereby embedding much more into the catalytic sites (Figure 4B) and retracing the mode of interaction proposed for phenolic substrates [27]. In addition, the formation of the additional hydrogen bond was responsible of the higher score recorded for AFM1 within all of the laccase isoforms herein considered. Conversely, AFB1 was unable to sink into the site to the extent of AFB1 since the hydroxyl-free difuran moiety did not find the energetic favors for being close to the aspartate side chain.
The incapability of AFB1 to positively interact with the gamma isoform may be explained by the diverse capability of AFB1 and AFM1 to sink within the catalytic site, where AFM1 was found closer to the bottom of the pocket. Indeed, the additional loop at the entrance of the binding site of the gamma isoform redefined markedly the available space for ligands in the upper portion of the pocket (Figure 5) and prevented the proper accommodation of AFB1.

3. Discussion

The mitigation of mycotoxin content in food and feed is undoubtedly a major task for safeguarding health and global trade. Besides the use of good agricultural practices and crop breeding, the biological control of toxin accumulation in the final products by acting at pre- and post-harvest levels and during food processing proved to be an effective strategy [4]. In this framework, the search for enzymes able to convert mycotoxins into non- or low-toxic products has been the object of a growing number of studies. The main advantage of using enzyme-based strategies is the possibility to act at the different stages of food and feed production chains. Indeed, enzymes are currently considered as food/feed additives or agents during the from-field-to-fork pathway, and they are aimed at reducing the carryover and accumulation in the final products [30]. Nonetheless, while the safety and security of genetically modified organisms for health and environment are under a heated scientific debate, the genome engineering by introducing effective enzymes in susceptible hosts or detoxifying microorganisms can be thought as a possible (future) strategy (e.g., ref. [31,32]).
In this scenario, novel strategies for a more effective search of mycotoxin-degrading enzymes should be implemented. The upstream investigation via in silico approaches can be a straightforward choice to significantly extend the explorable space in the early stage providing reliable and informative insights on the enzymes–substrate interaction, also in the view of the evidence-based preliminary hierachization of candidates for the experimental trials.
As a proof of concept, in the present work, we addressed the case study of the interaction between AFs and laccase enzymes from T. versicolor. The tertiary structures of gamma and delta isoforms, which are not structurally resolved up to now, were obtained through the homology modeling on the crystallographic structure of the homologous beta isoform (further details are reported in Section 5). On the basis of the fit-for-purpose validation, the 3D receptor modeling turned out to be an effective strategy for estimating the enzyme–substrate interaction for all of the isoforms under investigation. Actually, the reliability of 3D models that were derived from the primary structure of proteins is among the most relevant outcomes pinpointed herein. Indeed, the possibility to use the primary structure for deriving reliable 3D libraries of enzymes may significantly expand the explorable space of research beyond the enzymes that are commercially available or structurally and functionally known so far. In this respect, the advances in structural biology and the whole-genome sequencing data are providing a growing number of high-resolution structures to derive 3D models and a wealth of newly identified sequences of putative proteins for an even more wide-ranging screening.
The degradation by means of laccase enzymes from T. versicolor is considered among the most promising and cost-effective enzymatic strategies for the mitigation of AF content [14]. Typically, the development of enzyme-based strategies requires the precise understanding of the specific enzymes–substrate activity, especially in the presence of different isoforms, in order to isolate the most suitable for the purpose. To this end, it is mandatory to gain knowledge on the substrate–enzyme interaction from a structural perspective, thereby understanding in-depth the mechanism of catalysis and deciphering the reasons underlying the formation of degraded products. Taken as a whole, this background of knowledge may reduce the extent of the try-and-error timeframe during the optimization of degradation processes. However, the relative effectiveness of the various laccase isoforms from T. versicolor is still unknown, as only unspecified mixtures of the various isoforms have been assessed up to now. Furthermore, the structural organization of AFs within the laccase binding sites has not been elucidated yet. Overall, this scenario eventually makes it hard to refine more effective strategies based on selected enzymes. In this context, the present work investigated the arrangement of AFB1 and AFM1 within the binding site of the beta, delta and gamma laccase isoforms with the aim to find out some possible differences in the accommodation of AFs in the catalytic sites. On the basis of our findings, relevant structural differences between gamma and the other isoforms have been pointed out in terms of accessibility of the catalytic site. In fact, AFB1 were found able to accommodate within beta and delta, but not within gamma due to the extension of a loop lining the binding site. In particular, the re-shaping of the upper portion of the pocket was responsible for the inappropriate accommodation of AFB1 since the hydrophobic difuran moiety has been unfavorably arranged too close to the hydrophilic space at the bottom of the pocket. Notably, the pathway of entrance toward the catalytic site of enzymes may strongly influence the reaction yield and commonly concur to determine the substrate specificity [33,34]. Specifically, it has been previously reported that mutation at the C-terminus of orthologous fungal laccases may affect the enzyme activity influencing the accessibility to the binding sites [35,36]. Accordingly, this feature can be accounted for gaining more specificity for the laccase enzymes from T. versicolor since the low substrate specificity is the major drawback in the application on real food and feed matrices. Indeed, laccases can degrade a wide spectrum of compounds, including a wealth of healthy low molecular weight food and feed constituents (e.g., polyphenols) [37], thus possibly causing an overall pauperization of the treated products. Therefore, the engineering of such a loop might be a straightforward strategy to modulate the substrate specificity of laccases without significantly altering the binding site and preserving as much as possible the catalytic environment. To this end, the gamma isoform can be considered as the most suitable among the various isoforms holding an extended loop at the entrance of the catalytic site, which might be accounted for mutations, while the other isoforms have a direct access.
AFM1 was found able to positively interact within the catalytic sites of all the isoforms herein considered. In this case, the presence of the hydroxyl group on the difuran moiety facilitated a deeper sinking into the pocket that allowed the accommodation also within the gamma isoform. Notably, AFM1 recorded higher scores than AFB1 within all of the catalytic sites due to the formation of an additional hydrogen bond. The gain of enthalpy may be responsible for an increase in substrate–enzyme affinity and, eventually, may cause a higher degrading yield. In this respect, the full degradation of AFM1, by laccases from the edible mushroom Pleurotus pulmonarius, was reported by Loi and coworkers [38], thus supporting the strong degradation of hydroxylated forms in accordance with the well-known activity of laccases on poly-phenolic molecules [27].
In the framework of effectively reducing the content of toxicants, the formation of more toxic by-products must be carefully avoided. In this respect, a decreased (geno)toxicity for AFB1 after treatment with laccases has been already reported. The modification at the level of difuran moiety—which is responsible for the toxic action—has been proposed as the possible mechanism [15]. However, neither the exact chemistry of the degrading event nor the structure(s) of reaction product(s) have been elucidated so far. The computed architectures of binding revealed that both AFs structures (including the difuran moieties) were found almost entirely arranged within the proper range of distance from the catalytic hystidine to undergo oxidation. Thus, some other parts of the AFB1 molecules might undergo modifications. Moreover, it is worth mentioning that AFM1 showed some differences in the pattern of interaction with respect to AFB1 as the additional hydroxyl group on the difuran moiety interacted directly with the catalytic core. Accordingly, AFM1 might undergo the same degrading route of phenolic compounds via the electron/proton transfer mechanism [27], which is instead less likely to occur for AFB1 due to the lack of the additional hydroxyl groups. Therefore, differences in terms of sites, type of modification and chemical structures of products between AFB1 and AFM1 cannot be excluded throughout and should be carefully evaluated to rule out the formation of possible toxic byproducts.

4. Conclusions

In conclusion, the in silico simulations proved to be effective analytical tools to investigate the enzyme–substrate interaction, correlating with the affinity of binding. Specifically, the 3D modeling approach provided, for the first time, structural insights on the laccase–aflatoxin interaction, which may be useful for the evidence-based hierarchization of enzymes to be used in further experimental trials.
The modeling of laccase enzyme has been shown to be reliable from previous works (e.g., ref. [39,40]). However, the in silico screening of multiple laccase isoforms in the framework of AF control has been never used before. In more detail, AFM1 was found to be able to arrange positively within all the isoforms herein considered, while AFB1 was able to arrange within beta and delta but not within gamma. Accordingly, the low degradation yield of AFB1 by laccase gamma can be hypothesized. Furthermore, AFB1 and AFM1 showed different binding architectures in arranging within laccase catalytic sites. Therefore, it cannot be excluded that AFB1 and AFM1 undergo different modifications in different regions of the molecule, thus forming degraded products that are chemically different. This might also cause the differential formation of toxic by-products. On the other hand, the effects of the extended loop of the gamma isoform in diversifying the enzyme–substrate recognition can be accounted for developing future strategies to modulate the substrate specificity. Taken together, these results may provide a basic foothold for addressing future studies from a more informed perspective.
Finally, it is worth mentioning the degradation of AFM1, which is the main mammal metabolite. The carryover phenomenon of this metabolite in dairy products poses serious health concerns, and, nowadays, the strategies for reducing the contamination levels in milk and derived products primarily act on reducing the consumption of AFB1-contaminated feed by dairy animals. However, the use of AFM1-degrading enzymes on milk might be an additional strategy to further mitigate the contamination level of AFM1 in milk itself and dairy products.

5. Materials and Methods

5.1. Homology Modeling and Sequence Analysis

The crystallographic structure of the enzyme beta laccase from Trametes versicolor (PDB code 1KYA [16]) was the template for the homology modeling of gamma and delta isoforms. The Modeller software, version 9.14 (copyright © 1989-2016 Andrej Sali; maintained by Ben Webb at the Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, California Institute for Quantitative Biomedical Research, Mission Bay Byers Hall, University of California San Francisco, San Francisco, CA, USA) was used [41]. The D206A beta isoform model was obtained by manually editing the wild type structure with the software Sybyl, version 8.1 (Certara USA, Princeton, NJ, USA). For sequence analysis, a local pairwise alignment was conducted by using the on-line tool EMBOSS-Water Pairwise Sequence Alignment (EMBL-EBI, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK; http://www.ebi.ac.uk) and the Smith–Waterman algorithm was chosen.

5.2. Molecular Modeling

All protein structures and ligands were processed by using the software Sybyl, version 8.1 (Certara USA, Princeton, NJ, USA). All atoms were checked for atom- and bond-type assignments. Amino- and carboxyl-terminal groups were set as protonated and deprotonated, respectively. Hydrogen atoms were computationally added to the protein and energy-minimized using the Powell algorithm with a coverage gradient of ≤0.5 kcal (mol·Å)−1 and a maximum of 1500 cycles.

5.3. Pharmacophore Models

The ligand binding site was defined by using the Flapsite tool of the FLAP (Fingerprint for Ligand And Protein) software version 2.0 (Molecular Discovery Ltd., Borehamwood, Hertfordshire, UK; http://www.moldiscovery.com) [42], while the GRID algorithm [43,44] was used to investigate the corresponding pharmacophoric space. The hydrophobic (DRY) probe was used to describe the potential hydrophobic interactions, while the sp2 carbonyl oxygen (O) and the neutral flat amino (N1) probes were used to describe the hydrogen bond acceptor and donor capacity of the target, respectively. All images were obtained using the software PyMol version 1.7 (Schrödinger, New York, NY, USA; http://www.pymol.org).

5.4. Docking Simulations and Re-Scoring Procedures

The coupling of GOLD (Genetic Optimization for Ligand Docking), as docking software, and HINT [45], as rescoring function, was chosen on the basis of previous studies demonstrating the higher reliability of HINT with respect to other scoring functions in estimating the ligand binding free energies and evaluating the protein–ligand complex formation [19,23,46]. Software setting and rescoring procedures reported by Ehrlich were used [47]. In more detail, HINT score provides the evaluation of thermodynamic benefits of protein–ligand interaction, and relates with the ΔG° of complex formation [22,24,25]. Specifically, the empirical HINT scoring function implicitly considers enthalpic and entropic aspects of protein–ligand interaction using experimental Log Po/w measurements (partition coefficient for 1-octanol/water) as the basis of its force field. Indeed, from a mechanical point of view, the forces that drive the repartition of molecules between the two solvent phases also underline protein–ligand interaction, as well protein–protein interaction or ligand–ligand interaction. The HINT score is the sum of the all inter-atomic contributions from binding, thereby providing an empirical and quantitative estimate of the favors of the host–guest interaction from an atomic point of view. Thus, the higher the score, the more favored is the arrangement of ligands within the binding site [22,24,25,48]. The HINT equation is the following:
HINT   score   =   i j b i j = i j ( a i S i a j S j T i j R i j + r i j ) ,
where bij is the interaction score between atoms i and j, a is the hydrophobic atomic constant, S represents the solvent accessible surface area, Tij is a logic function assuming +1 or −1 values, depending on the nature of the interatomic interaction, and Rij and rij are functions of the distance between atoms i and j. Further details on the basic theory of HINT can be found in ref. [49,50,51].

Acknowledgments

We would like to acknowledge Glen E. Kellogg and Gabriele Cruciani for the courtesy of the HINT scoring function and the Flap software, respectively. We would like to also acknowledge Pietro Cozzini for the kind access to all the facilities of the Molecular Modeling Laboratory (Department of Food Science, University of Parma, Italy) and Elia Vighi for the valuable contribution with doing the analysis.

Author Contributions

L.D., G.G. and C.D. conceived and designed the experiments; L.D. performed the experiments; L.D., C.D., M.R. and G.G. contributed equally to analyzing data; and L.D. and C.D. contributed equally to writing the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Berthiller, F.; Crews, C.; Dall’Asta, C.; Saeger, S.D.; Haesaert, G.; Karlovsky, P.; Oswald, I.P.; Seefelder, W.; Speijers, G.; Stroka, J. Masked mycotoxins: A review. Mol. Nutr. Food Res. 2013, 57, 165–168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Dellafiora, L.; Perotti, A.; Galaverna, G.; Buschini, A.M.; Dall’Asta, C. On the masked mycotoxin zearalenone-14-glucoside. Does the mask truly hide? Toxicon 2016, 111, 139–142. [Google Scholar] [CrossRef] [PubMed]
  3. Wu, F.; Guclu, H. Aflatoxin regulations in a network of global maize trade. PLoS ONE 2012, 7, e45151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Jard, G.; Liboz, T.; Mathieu, F.; Guyonvarc’h, A.; Lebrihi, A. Review of mycotoxin reduction in food and feed: From prevention in the field to detoxification by adsorption or transformation. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2011, 28, 1590–1609. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Karlovsky, P. Detoxification strategies for mycotoxins in plant breeding. In Masked Mycotoxins in Food: Formation, Occurrence and Toxicological Relevance; Dall’Asta, C., Berthiller, F., Eds.; Royal Society of Chemistry: London, UK, 2016. [Google Scholar]
  6. Dellafiora, L.; Paolella, S.; Dall’Asta, C.; Dossena, A.; Cozzini, P.; Galaverna, G. Hybrid in silico/in vitro approach for the identification of angiotensin I converting enzyme inhibitory peptides from Parma dry-cured ham. J. Agric. Food Chem. 2015, 22, 6366–6375. [Google Scholar] [CrossRef] [PubMed]
  7. Kalyanaraman, C.; Jacobson, M.P. Studying enzyme-substrate specificity in silico: A case study of the Escherichia coli glycolysis pathway. Biochemistry 2010, 49, 4003–4005. [Google Scholar] [CrossRef] [PubMed]
  8. Wu, F.; Groopman, J.D.; Pestka, J.J. Public health impacts of foodborne mycotoxins. Annu. Rev. Food Sci. Technol. 2014, 5, 351–372. [Google Scholar] [CrossRef] [PubMed]
  9. European Food Safety Authority (EFSA). Opinion of the scientific panel on contaminants in the food chain [contam] related to the potential increase of consumer health risk by a possible increase of the existing maximum levels for aflatoxins in almonds, hazelnuts and pistachios and derived products. EFSA J. 2007, 446. [Google Scholar] [CrossRef]
  10. Raiola, A.; Tenore, G.C.; Manyes, L.; Meca, G.; Ritieni, A. Risk analysis of main mycotoxins occurring in food for children: An overview. Food Chem. Toxicol. 2015, 84, 169–180. [Google Scholar] [CrossRef] [PubMed]
  11. Prandini, A.; Tansini, G.; Sigolo, S.; Filippi, L.; Laporta, M.; Piva, G. On the occurrence of aflatoxin M1 in milk and dairy products. Food Chem. Toxicol. 2009, 47, 984–991. [Google Scholar] [CrossRef] [PubMed]
  12. Perrone, G.; Gallo, A.; Logrieco, A.F. Biodiversity of Aspergillus section Flavi in Europe in relation to the management of aflatoxin risk. Front. Microbiol. 2014, 5, 377. [Google Scholar] [CrossRef] [PubMed]
  13. Mate, D.M.; Alcalde, M. Laccase: A multi-purpose biocatalyst at the forefront of biotechnology. Microb. Biotechnol. 2016. [Google Scholar] [CrossRef] [PubMed]
  14. Scarpari, M.; Bello, C.; Pietricola, C.; Zaccaria, M.; Bertocchi, L.; Angelucci, A.; Ricciardi, M.R.; Scala, V.; Parroni, A.; Fabbri, A.A.; et al. Aflatoxin control in maize by Trametes versicolor. Toxins (Basel) 2014, 6, 3426–3437. [Google Scholar] [CrossRef] [PubMed]
  15. Zeinvand-Lorestani, H.; Sabzevari, O.; Setayesh, N.; Amini, M.; Nili-Ahmadabadi, A.; Faramarzi, M.A. Comparative study of in vitro prooxidative properties and genotoxicity induced by aflatoxin B1 and its laccase-mediated detoxification products. Chemosphere 2015, 135, 1–6. [Google Scholar] [CrossRef] [PubMed]
  16. Bertrand, T.; Jolivalt, C.; Briozzo, P.; Caminade, E.; Joly, N.; Madzak, C.; Mouqin, C. Crystal structure of a four-copper laccase complexed with an arylamine: Insights into substrate recognition and correlation with kinetics. Biochemistry 2002, 41, 7325–7333. [Google Scholar] [CrossRef] [PubMed]
  17. Dellafiora, L.; Mena, P.; Cozzini, P.; Brighenti, F.; Del Rio, D. Modelling the possible bioactivity of ellagitannin-derived metabolites. In silico tools to evaluate their potential xenoestrogenic behavior. Food Funct. 2013, 4, 1442–1451. [Google Scholar] [CrossRef] [PubMed]
  18. Dellafiora, L.; Mena, P.; Del Rio, D.; Cozzini, P. Modeling the effect of phase II conjugations on topoisomerase I poisoning: Pilot study with luteolin and quercetin. J. Agric. Food Chem. 2014, 62, 5881–5886. [Google Scholar] [CrossRef] [PubMed]
  19. Dellafiora, L.; Dall’Asta, C.; Cozzini, P. Ergot alkaloids: From witchcraft till in silico analysis. Multi-receptor analysis of ergotamine metabolites. Toxicol. Rep. 2015, 2, 535–545. [Google Scholar] [CrossRef]
  20. Madzak, C.; Mimmi, M.C.; Caminade, E.; Brault, A.; Baumberger, S.; Briozzo, P.; Mougin, C.; Jolivalt, C. Shifting the optimal pH of activity for a laccase from the fungus Trametes versicolor by structure-based mutagenesis. Protein Eng. Des. Sel. 2006, 19, 77–84. [Google Scholar] [CrossRef] [PubMed]
  21. Cozzini, P.; Dellafiora, L. In silico approach to evaluate molecular interaction between mycotoxins and the estrogen receptors ligand binding domain: A case study on zearalenone and its metabolites. Toxicol. Lett. 2012, 214, 81–85. [Google Scholar] [CrossRef] [PubMed]
  22. Cozzini, P.; Fornabaio, M.; Marabotti, A.; Abraham, D.J.; Kellogg, G.E.; Mozzarelli, A. Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water. J. Med. Chem. 2002, 45, 2469–2483. [Google Scholar] [CrossRef] [PubMed]
  23. Dellafiora, L.; Dall’Asta, C.; Cruciani, G.; Galaverna, G.; Cozzini, P. Molecular modelling approach to evaluate poisoning of topoisomerase I by alternariol derivatives. Food Chem. 2015, 189, 93–101. [Google Scholar] [CrossRef] [PubMed]
  24. Fornabaio, M.; Cozzini, P.; Mozzarelli, A.; Abraham, D.J.; Kellogg, G.E. Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 2. Computational titration and pH effects in molecular models of neuraminidase-inhibitor complexes. J. Med. Chem. 2003, 46, 4487–4500. [Google Scholar] [CrossRef] [PubMed]
  25. Fornabaio, M.; Spirakis, F.; Mozzarelli, A.; Cozzini, P.; Abraham, D.J.; Kellogg, G.E. Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 3. The free energy contribution of structural water molecules in HIV-1 protease complexes. J. Med. Chem. 2004, 47, 4507–4516. [Google Scholar] [CrossRef] [PubMed]
  26. Christensen, N.J.; Kepp, K.P. Setting the stage for electron transfer: Molecular basis of ABTS-binding to four laccases from Trametes versicolor at variable pH and protein oxidation state. J. Mol. Catal. B Enzym. 2014, 100, 68–77. [Google Scholar] [CrossRef]
  27. Galli, C.; Madzak, C.; Vadalà, R.; Jolivalt, C.; Gentili, P. Concerted electron/proton transfer mechanism in the oxidation of phenols by laccase. ChemBioChem 2013, 14, 2500–2505. [Google Scholar] [CrossRef] [PubMed]
  28. Lee, D.; Redfern, O.; Orengo, C. Predicting protein function from sequence and structure. Nat. Rev. Mol. Cell Biol. 2007, 8, 995–1005. [Google Scholar] [CrossRef] [PubMed]
  29. Enguita, F.J.; Marçal, D.; Martins, L.O.; Grenha, R.; Henriques, A.O.; Lindley, P.F.; Carrondo, M.A. Substrate and dioxygen binding to the endospore coat laccase from Bacillus subtilis. J. Biol. Chem. 2004, 279, 23472–23476. [Google Scholar] [CrossRef] [PubMed]
  30. Hahn, I.; Thamhesl, M.; Apfelthaler, E.; Klingenbrunner, V.; Hametner, C.; Krska, R.; Schatzmayr, G.; Moll, W.-D.; Berthiller, F.; Schwartz-Zimmermann, H.E. Characterisation and determination of metabolites formed by microbial and enzymatic degradation of ergot alkaloids. World Mycotoxins J. 2015, 8, 393–404. [Google Scholar] [CrossRef]
  31. Igawa, T.; Takahashi-Ando, N.; Ochiai, N.; Ohsato, S.; Shimizu, T.; Kudo, T.; Yamaguchi, I.; Kimura, M. Reduced contamination by the Fusarium mycotoxin zearalenone in maize kernels through genetic modification with a detoxification gene. Appl. Environ. Microbiol. 2007, 73, 1622–1629. [Google Scholar] [CrossRef] [PubMed]
  32. Munkvold, G.P. Cultural and genetic approaches to managing mycotoxins in maize. Annu. Rev. Phytopathol. 2003, 44, 99–116. [Google Scholar] [CrossRef] [PubMed]
  33. Gerike, U.; Danson, M.J.; Hough, D.W. Cold-active citrate synthase: Mutagenesis of active-site residues. Protein Eng. 2001, 14, 655–661. [Google Scholar] [CrossRef] [PubMed]
  34. Leferink, N.G.; Antonyuk, S.V.; Houwman, J.A.; Scrutton, N.S.; Eady, R.R.; Hasnain, S.S. Impact of residues remote from the catalytic centre on enzyme catalysis of copper nitrite reductase. Nat. Commun. 2014, 5, 4395. [Google Scholar] [CrossRef] [PubMed]
  35. Bleve, G.; Lezzi, C.; Spagnolo, S.; Tasco, G.; Tufariello, M.; Casadio, R.; Mita, G.; Rampino, P.; Grieco, F. Role of the C-terminus of Pleurotus eryngii Ery4 laccase in determining enzyme structure, catalytic properties and stability. Protein Eng. Des. Sel. 2013, 26, 1–13. [Google Scholar] [CrossRef] [PubMed]
  36. Andberg, M.; Hakulinen, N.; Auer, S.; Saloheimo, M.; Koivula, A.; Rouvinen, J.; Kruus, K. Essential role of the C-terminus in Melanocarpus albomyces laccase for enzyme production, catalytic properties and structure. FEBS J. 2009, 276, 6285–6300. [Google Scholar] [CrossRef] [PubMed]
  37. Reiss, R.; Ihssen, J.; Richter, M.; Eichhorn, E.; Schilling, B.; Thöny-Meyer, L. Laccase versus laccase-like multi-copper oxidase: A comparative study of similar enzymes with diverse substrate spectra. PLoS ONE 2013, 8, e65633. [Google Scholar] [CrossRef] [PubMed]
  38. Loi, M.; Fanelli, F.; Zucca, P.; Liuzzi, V.C.; Quintieri, L.; Cimmarusti, M.T.; Monaci, L.; Haidukowski, M.; Logrieco, A.F.; Sanjust, E.; et al. Aflatoxin B1 and M1 degradation by lac2 from Pleurotus pulmonarius and redox mediators. Toxins (Basel) 2016, 8, E245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Cambria, M.T.; Di Marino, D.; Falconi, M.; Garavaglia, S.; Cambria, A. Docking simulation and competitive experiments validate the interaction between the 2,5-xylidine inhibitor and Rigidoporus lignosus laccase. J. Biomol. Struct. Dyn. 2010, 27, 501–510. [Google Scholar] [CrossRef] [PubMed]
  40. Suresh, P.S.; Kumar, A.; Kumar, R.; Singh, V.P. An in silico [correction of insilico] approach to bioremediation: Laccase as a case study. J. Mol. Graph. Model. 2008, 26, 845–849. [Google Scholar] [CrossRef] [PubMed]
  41. Sali, A.; Blundell, T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234, 779–815. [Google Scholar] [CrossRef] [PubMed]
  42. Baroni, M.; Cruciani, G.; Sciabola, S.; Perruccio, F.; Mason, J.S. A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application. J. Chem. Inf. Model. 2007, 47, 279–294. [Google Scholar] [CrossRef] [PubMed]
  43. Goodford, P.J. A computational procedure for determining energetically favourable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28, 849–857. [Google Scholar] [CrossRef] [PubMed]
  44. Carosati, E.; Sciabola, S.; Cruciani, G. Hydrogen bonding interactions of covalently bonded fluorine atoms: From crystallographic data to a new angular function in the GRID force field. J. Med. Chem. 2004, 47, 5114–5125. [Google Scholar] [CrossRef] [PubMed]
  45. Kellogg, E.G.; Abraham, D.J. Hydrophobicity: Is LogPo/w more than the sum of its parts? Eur. J. Med. Chem. 2000, 37, 651–661. [Google Scholar] [CrossRef]
  46. Dellafiora, L.; Galaverna, G.; Dall’Asta, C.; Cozzini, P. Hazard identification of cis/trans-zearalenone through the looking-glass. Food Chem. Toxicol. 2015, 86, 65–71. [Google Scholar] [CrossRef] [PubMed]
  47. Ehrlich, V.A.; Dellafiora, L.; Mollergues, J.; Dall’Asta, C.; Serrant, P.; Marin-Kuan, M.; Lo Piparo, E.; Schilter, B.; Cozzini, P. Hazard assessment through hybrid in vitro/in silico approach: The case of zearalenone. ALTEX 2015, 32, 275–286. [Google Scholar] [CrossRef] [PubMed]
  48. Marabotti, A.; Spyrakis, F.; Facchiano, A.; Cozzini, P.; Alberti, S.; Kellogg, G.E.; Mozzarelli, A. Energy-based prediction of amino acid-nucleotide base recognition. J. Comput. Chem. 2008, 29, 1955–1969. [Google Scholar] [CrossRef] [PubMed]
  49. Kellogg, G.E.; Burnett, J.C.; Abraham, D.J. Very empirical treatment of solvation and entropy: A force field derived from LogPo/w. J. Comput. Aided Mol. Des. 2001, 15, 381–393. [Google Scholar] [CrossRef] [PubMed]
  50. Kellogg, G.E.; Fornabaio, M.; Spyrakis, F.; Lodola, A.; Cozzini, P.; Mozzarelli, A.; Abraham, D.J. Getting it right: Modeling of pH, solvent and “Nearly” Everything else in virtual screening of biological targets. J. Mol. Graph. Model. 2004, 22, 479–486. [Google Scholar] [CrossRef] [PubMed]
  51. Sarkar, A.; Kellogg, G.E. Hydrophobicity-shake flasks, protein folding and drug discovery. Curr. Top. Med. Chem. 2010, 10, 67–83. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structure of aflatoxin B1 (A) and aflatoxin M1 (B).
Figure 1. Chemical structure of aflatoxin B1 (A) and aflatoxin M1 (B).
Toxins 09 00017 g001
Figure 2. The sequence alignment (A) and pharmacophoric analysis of beta (B), gamma (C) and delta (D) laccase isoforms from T. versicolor. In the sequence alignment (box A), dots represent matching residues while dashes indicate gaps (red spots in the gap fraction blue bar). Residues of the binding site are highlighted in yellow while the green box indicates an extended region of the gamma isoform lining the catalytic site. The overall 3D structure of the beta isoform is also reported to provide localization of the binding site (colored in yellow). In the pharmacophoric analysis (boxes B, C and D), white, red, and blue contours identify regions sterically and energetically favorable for hydrophobic, H-bond acceptor, and H-bond donor groups, respectively. Spheres indicate Cu ions. The green box indicates the extended region of the gamma isoform.
Figure 2. The sequence alignment (A) and pharmacophoric analysis of beta (B), gamma (C) and delta (D) laccase isoforms from T. versicolor. In the sequence alignment (box A), dots represent matching residues while dashes indicate gaps (red spots in the gap fraction blue bar). Residues of the binding site are highlighted in yellow while the green box indicates an extended region of the gamma isoform lining the catalytic site. The overall 3D structure of the beta isoform is also reported to provide localization of the binding site (colored in yellow). In the pharmacophoric analysis (boxes B, C and D), white, red, and blue contours identify regions sterically and energetically favorable for hydrophobic, H-bond acceptor, and H-bond donor groups, respectively. Spheres indicate Cu ions. The green box indicates the extended region of the gamma isoform.
Toxins 09 00017 g002
Figure 3. Binding architecture of ABTS. Proteins are represented in cartoon and surface, ABTS and residues of binding sites are represented in sticks. Cu at the T1 site is represented by the red sphere and the catalytic histidine is colored in red. ABTS electron donor region is highlighted with the yellow box, while interatomic distances are indicated by yellow dashed lines. (A) calculated surface interaction with beta laccase from T. versicolor; (B) crystallographic surface interaction with CotA laccase from Bacillus subtilis [29]; (C) detail of binding architecture with beta laccase from T. versicolor; and (D) detail of binding architecture with CotA laccase from B. subtilis [29].
Figure 3. Binding architecture of ABTS. Proteins are represented in cartoon and surface, ABTS and residues of binding sites are represented in sticks. Cu at the T1 site is represented by the red sphere and the catalytic histidine is colored in red. ABTS electron donor region is highlighted with the yellow box, while interatomic distances are indicated by yellow dashed lines. (A) calculated surface interaction with beta laccase from T. versicolor; (B) crystallographic surface interaction with CotA laccase from Bacillus subtilis [29]; (C) detail of binding architecture with beta laccase from T. versicolor; and (D) detail of binding architecture with CotA laccase from B. subtilis [29].
Toxins 09 00017 g003
Figure 4. Binding architecture of AFB1 (A) and AFM1 (B) within the beta isoform. Proteins are represented in with cartoons and cut surfaces, and ligands and amino acids side-chains are represented with sticks. The Cu ions are represented with spheres. Yellow dotted lines indicate H-bonds.
Figure 4. Binding architecture of AFB1 (A) and AFM1 (B) within the beta isoform. Proteins are represented in with cartoons and cut surfaces, and ligands and amino acids side-chains are represented with sticks. The Cu ions are represented with spheres. Yellow dotted lines indicate H-bonds.
Toxins 09 00017 g004
Figure 5. Details of ligand binding site of laccase isoforms. Proteins are represented with cut surfaces and ligands with sticks. The yellow box indicates the additional volume in the gamma isoform binding site due to the presence of the extended loop. (A) AFB1 within the beta isoform pocket; (B) AFB1 within the delta isoform pocket; and (C) gamma isoform pocket.
Figure 5. Details of ligand binding site of laccase isoforms. Proteins are represented with cut surfaces and ligands with sticks. The yellow box indicates the additional volume in the gamma isoform binding site due to the presence of the extended loop. (A) AFB1 within the beta isoform pocket; (B) AFB1 within the delta isoform pocket; and (C) gamma isoform pocket.
Toxins 09 00017 g005
Table 1. Comparison of experimental affinity and HINT (Hydrophatic INTeractions) scores of ABTS (2,2′-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid) within the various laccase isoforms.
Table 1. Comparison of experimental affinity and HINT (Hydrophatic INTeractions) scores of ABTS (2,2′-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid) within the various laccase isoforms.
Laccase IsoformExperimental Affinity Rank 1HINT Score
Beta1430
Gamma2206
Delta3104
1 As reported by Christensen and co-workers [26].
Table 2. Comparison of experimental affinity and HINT scores of ABTS and 2,6-dimethoxyphenol within the wild type and mutated form of beta isoform.
Table 2. Comparison of experimental affinity and HINT scores of ABTS and 2,6-dimethoxyphenol within the wild type and mutated form of beta isoform.
Laccase IsoformABTS2,6-dimethoxyphenol
Experimental Affinity Rank 1HINT ScoreExperimental Affinity Rank 1HINT Score
Beta wild type24301500
Beta D206A14952203
1 As reported by Madzak and co-workers [20].
Table 3. HINT scores of aflatoxin B1 (AFB1)and aflatoxin M1 (AFM1)within the various laccase isoforms.
Table 3. HINT scores of aflatoxin B1 (AFB1)and aflatoxin M1 (AFM1)within the various laccase isoforms.
Laccase IsoformHINT Scores
AFB1AFM1
Beta248373
Gamma−199372
Delta291339

Share and Cite

MDPI and ACS Style

Dellafiora, L.; Galaverna, G.; Reverberi, M.; Dall’Asta, C. Degradation of Aflatoxins by Means of Laccases from Trametes versicolor: An In Silico Insight. Toxins 2017, 9, 17. https://doi.org/10.3390/toxins9010017

AMA Style

Dellafiora L, Galaverna G, Reverberi M, Dall’Asta C. Degradation of Aflatoxins by Means of Laccases from Trametes versicolor: An In Silico Insight. Toxins. 2017; 9(1):17. https://doi.org/10.3390/toxins9010017

Chicago/Turabian Style

Dellafiora, Luca, Gianni Galaverna, Massimo Reverberi, and Chiara Dall’Asta. 2017. "Degradation of Aflatoxins by Means of Laccases from Trametes versicolor: An In Silico Insight" Toxins 9, no. 1: 17. https://doi.org/10.3390/toxins9010017

APA Style

Dellafiora, L., Galaverna, G., Reverberi, M., & Dall’Asta, C. (2017). Degradation of Aflatoxins by Means of Laccases from Trametes versicolor: An In Silico Insight. Toxins, 9(1), 17. https://doi.org/10.3390/toxins9010017

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop